Fredric N. Eshelman, Director, 10% Owner at Furiex Pharmaceuticals, Inc. (FURX), bought 78,326 shares at $19.04 ($1.5M) on 2012-06-14, disclosed to the SEC on 2012-06-15.
Open-market purchase of $1.5M FURX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.33 | 44,193 | $810K | 55.5% |
| 2 | $19.04 | 34,133 | $650K | 44.5% |
| Total | $18.64 avg | 78,326 | $1.5M | 100% |
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |